Hemogenyx Pharmaceuticals Share News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

794.00 -35.50 (-4.44%)

Bid:

735.00

Ask:

794.00

Spread: 59.00 (8.027%)

Market Cap: £53.99m

Last checked at -

Intraday Hemogenyx Pharmaceuticals Share Chart

REMOVE ADS

Hemogenyx Pharmaceuticals News

Hemogenyx opens first clinical site for leukaemia therapy trial

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday reported the opening of the first clinical site in its HG-CT-1 phase 1 trial.

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

IN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trial

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for blood diseases - Schedules the opening of the first c...

Hemogenyx shares boosted by partner investment

(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investme...